PD-L1immunecheckpoint相关论文
Notch signaling inhibitor and anti-PD-L1 antibody combination therapies decelerate tumor progression
...
Notch signaling inhibitor and anti-PD-L1 antibody combination therapies decelerate tumor progression
Objective::Pancreatic cancer (PC) is a highly lethal malignancy with an immunosuppressive environment. Yet, current immu......